Personal tools

Coexpression cluster:C4683: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=DOID:14566!4.37e-27!239;DOID:162!4.18e-26!235;DOID:0050687!1.35e-15!143;DOID:0050686!1.87e-12!137;DOID:305!1.66e-08!106
|ontology_enrichment_disease=DOID:14566!4.37e-27!239;DOID:162!4.18e-26!235;DOID:0050687!1.35e-15!143;DOID:0050686!1.87e-12!137;DOID:305!1.66e-08!106
|ontology_enrichment_uberon=UBERON:0002097!9.80e-08!40;UBERON:0002199!1.48e-07!45;UBERON:0002416!1.48e-07!45;UBERON:0003102!9.76e-07!95
|ontology_enrichment_uberon=UBERON:0002097!9.80e-08!40;UBERON:0002199!1.48e-07!45;UBERON:0002416!1.48e-07!45;UBERON:0003102!9.76e-07!95
|pathway_enrichment=4.79354634032066e-06;0.00151715741671149;2;63;Aminoacyl-tRNA biosynthesis (KEGG):00970!0.000216998173040322;0.045786614511508;2;421;Gene Expression (Reactome):REACT_71!2.5771754517853e-07;0.00016313520609801;2;15;{EPRS,15} (Static Module):NA
}}
}}

Revision as of 15:03, 13 July 2012


Full id: C4683_Preadipocyte_giant_Smooth_Fibroblast_melanoma_Ewing_mesenchymal



Phase1 CAGE Peaks

Hg19::chr7:30634439..30634572,+p1@GARS
Hg19::chr9:95055931..95055951,-p2@IARS
Hg19::chr9:95055956..95056004,-p1@IARS


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


p.valueFDRnGenesnPathwayName
4.79354634032066e-060.00151715741671149263Aminoacyl-tRNA biosynthesis (KEGG):00970
0.0002169981730403220.0457866145115082421Gene Expression (Reactome):REACT_71
2.5771754517853e-070.00016313520609801215{EPRS,15} (Static Module):NA



Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0043038amino acid activation0.000174999140341419
GO:0043039tRNA aminoacylation0.000174999140341419
GO:0006418tRNA aminoacylation for protein translation0.000174999140341419
GO:0016875ligase activity, forming carbon-oxygen bonds0.000174999140341419
GO:0016876ligase activity, forming aminoacyl-tRNA and related compounds0.000174999140341419
GO:0004812aminoacyl-tRNA ligase activity0.000174999140341419
GO:0006399tRNA metabolic process0.000386485029551408
GO:0005625soluble fraction0.000389759114775116
GO:0006520amino acid metabolic process0.00142466075754636
GO:0006519amino acid and derivative metabolic process0.0017073527239818
GO:0009308amine metabolic process0.0017073527239818
GO:0004820glycine-tRNA ligase activity0.0017073527239818
GO:0006426glycyl-tRNA aminoacylation0.0017073527239818
GO:0016874ligase activity0.0017073527239818
GO:0006807nitrogen compound metabolic process0.00175001427911881
GO:0004822isoleucine-tRNA ligase activity0.0019143533411074
GO:0006428isoleucyl-tRNA aminoacylation0.0019143533411074
GO:0019752carboxylic acid metabolic process0.0019143533411074
GO:0006082organic acid metabolic process0.0019143533411074
GO:0000267cell fraction0.00232389136198941
GO:0006412translation0.003964147193353
GO:0009059macromolecule biosynthetic process0.00624735990464482
GO:0030141secretory granule0.00624735990464482
GO:0045055regulated secretory pathway0.00857402855122935
GO:0044249cellular biosynthetic process0.00858732448264697
GO:0009058biosynthetic process0.0132407701752879
GO:0005524ATP binding0.0161792710118105
GO:0032559adenyl ribonucleotide binding0.0161792710118105
GO:0030554adenyl nucleotide binding0.0169818384858086
GO:0032553ribonucleotide binding0.0227218286099275
GO:0032555purine ribonucleotide binding0.0227218286099275
GO:0017076purine nucleotide binding0.0236857190230647
GO:0045045secretory pathway0.0281591605431612
GO:0016070RNA metabolic process0.0290317417570611
GO:0000166nucleotide binding0.0297015403698842
GO:0032940secretion by cell0.0319161544909049
GO:0016023cytoplasmic membrane-bound vesicle0.035806545811623
GO:0031988membrane-bound vesicle0.035806545811623
GO:0046903secretion0.0380420856223659
GO:0031410cytoplasmic vesicle0.0404963451850661
GO:0031982vesicle0.0404963451850661
GO:0010467gene expression0.0404963451850661
GO:0044267cellular protein metabolic process0.0414628423752696
GO:0044260cellular macromolecule metabolic process0.0415722779567392
GO:0006139nucleobase, nucleoside, nucleotide and nucleic acid metabolic process0.0426561100799306
GO:0019538protein metabolic process0.0426561100799306



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
animal cell2.40e-25679
eukaryotic cell2.40e-25679
non-terminally differentiated cell6.09e-18180
fibroblast6.53e-1275
native cell1.13e-11722
skin fibroblast6.30e-0923
somatic cell3.60e-08591
embryonic cell3.56e-07248
Uber Anatomy
Ontology termp-valuen
skin of body9.80e-0840
integument1.48e-0745
integumental system1.48e-0745
surface structure9.76e-0795
Disease
Ontology termp-valuen
disease of cellular proliferation4.37e-27239
cancer4.18e-26235
cell type cancer1.35e-15143
organ system cancer1.87e-12137
carcinoma1.66e-08106


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.